KO Short Book Collapses After Q3 Print as Analysts Lift Targets

KO reported Q3 results on October 27 and the bears retreated fast: short interest fell 16% over the week to 1.11% of the free float, the sharpest weekly unwind in the dataset this year.

The scale of that reversal is the defining fact of the week. Shares short dropped from a peak near 57 million in mid-October to 47.7 million by October 27, erasing the bulk of the rebuild that had accumulated through the month. That peak was itself the highest level in at least a year, the product of a near-31% week-on-week jump documented in the weeks before the print. The post-earnings washout brings the book back toward September levels, though it remains roughly 17% above the trough of around 39 million shares from that period. The borrow market offers no friction to anyone still wanting to move: availability is effectively unconstrained, running above 9,000% of shares short, and the cost to borrow has fallen to 0.36%, down 29% on the week and near the bottom of its recent range. There is no squeeze pressure here, just a clean reduction in a position that was not rewarded by the print.

The stock itself gave back ground despite the short cover. KO fell 2.5% over the week to $91.18, slightly worse than the median weekly move of minus 0.3% for its closest peers. PEP shed 0.4% over the same stretch, KDP added 0.7%, and TAP lost 1.9%. That KO underperformed even as shorts were covering is notable: it suggests the stock's weakness was price-driven rather than technically amplified. Options positioning is calm. The put/call ratio is running at 0.86, slightly below its 20-day average of 0.89 and well within the 52-week range of 0.63 to 1.16. There is no particular defensiveness in the options market after the print.

The Street moved firmly in one direction the moment results crossed. Morgan Stanley raised its target from $100 to $103 while maintaining Overweight. TD Cowen lifted from $100 to $104, also Buy. Wells Fargo went further, moving from $90 to $100 on an Overweight. Piper Sandler added another raise to $103. The consensus mean now stands at $97.17, which implies roughly 6.5% upside from Tuesday's close. That gap is smaller than it was a week ago, when the stock was trading closer to $93 against targets in the $95 to $102 range, but the directional momentum from the analyst community is unambiguous. On valuation, the stock trades at 26.1 times earnings and 23.5 times EV/EBITDA, both of which have eased slightly over the past 30 days. The dividend yield factor ranks in the 93rd percentile and the analyst recommendation differential sits at the 98th percentile, reflecting how constructive consensus positioning has become.

The EV/EBITDA multiple has compressed modestly over the month even as the stock held near highs, which means the earnings base has been doing work. The bear case centres on organic sales headwinds from concentrate timing and foreign exchange exposure, risks the company has flagged itself. The bull case rests on a 200-brand portfolio, 30%-plus global CSD market share, and a $3 billion productivity programme that management has pointed to as the primary lever for margin improvement. Those competing narratives have not changed materially with the print; the short book simply decided the balance of risks was less attractive than it had been.

The next earnings event is on February 9, 2027, leaving 104 days for the post-print positioning to settle. The question in the near term is whether the short book continues to unwind toward September levels or stabilises here, and whether the stock can close the gap to the $97 consensus mean without a further catalyst.